{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:55:40Z","timestamp":1765281340999,"version":"3.46.0"},"reference-count":73,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.2090","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:31:25Z","timestamp":1763713885000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Janus kinase\/signal transducer and activator of transcription pathway in schizophrenia (Review)"],"prefix":"10.3892","volume":"24","author":[{"given":"Emmanouil","family":"Rizos","sequence":"first","affiliation":[{"name":"Second Department of Psychiatry, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Theleritis","sequence":"additional","affiliation":[{"name":"Second Department of Psychiatry, Attikon University General Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Tsoporis","sequence":"additional","affiliation":[{"name":"Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Katsantoni","sequence":"additional","affiliation":[{"name":"Basic Research Center, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"key20251209132257_b1-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1126\/science.1070532","article-title":"Schizophrenia: Diverse approaches to a complex disease","volume":"296","author":"Sawa","year":"2002","journal-title":"Science"},{"issue":"386","key":"key20251209132257_b2-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.12085","article-title":"Links between trauma and psychosis (Review)","volume":"26","author":"Giannopoulou","year":"2023","journal-title":"Exp Ther Med"},{"key":"key20251209132257_b3-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/schbul\/sbq051","article-title":"Migration, ethnicity, and psychosis: Toward a sociodevelopmental model","volume":"36","author":"Morgan","year":"2010","journal-title":"Schizophr Bull"},{"issue":"e1223","key":"key20251209132257_b4-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.188","article-title":"Accelerated DNA methylation age in adolescent girls: Associations with elevated diurnal cortisol and reduced hippocampal volume","volume":"7","author":"Davis","year":"2017","journal-title":"Transl Psychiatry"},{"issue":"688727","key":"key20251209132257_b5-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.688727","article-title":"Research progress on the correlation between epigenetics and Schizophrenia","volume":"15","author":"Chen","year":"2021","journal-title":"Front Neurosci"},{"key":"key20251209132257_b6-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1017\/S0033291720002421","article-title":"A systematic review on mediators between adversity and psychosis: Potential targets for treatment","volume":"50","author":"Alameda","year":"2020","journal-title":"Psychol Med"},{"issue":"130","key":"key20251209132257_b7-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13254","article-title":"Association of gut dysbiosis with first-episode psychosis (Review)","volume":"30","author":"Theleritis","year":"2024","journal-title":"Mol Med Rep"},{"key":"key20251209132257_b8-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/s0022-3956(99)00039-4","article-title":"Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the \u2018two hit hypothesis.\u2019","volume":"33","author":"Bayer","year":"1999","journal-title":"J Psychiatr Res"},{"issue":"201","key":"key20251209132257_b9-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13566","article-title":"Zinc in psychosis (Review)","volume":"32","author":"Theleritis","year":"2025","journal-title":"Mol Med Rep"},{"key":"key20251209132257_b10-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1600-0447.2010.01594.x","article-title":"Childhood trauma and increased stress sensitivity in psychosis","volume":"123","author":"Lardinois","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"key20251209132257_b11-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.biopsych.2013.02.016","article-title":"Cortisol levels and risk for psychosis: Initial findings from the North American prodrome longitudinal study","volume":"74","author":"Walker","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key20251209132257_b12-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/archpsyc.57.10.925","article-title":"Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders","volume":"57","author":"Sapolsky","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"key20251209132257_b13-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.schres.2005.11.004","article-title":"Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies","volume":"82","author":"Vita","year":"2006","journal-title":"Schizophr Res"},{"key":"key20251209132257_b14-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1503\/jpn.100048","article-title":"Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders","volume":"36","author":"Thompson Ray","year":"2011","journal-title":"J Psychiatry Neurosci JPN"},{"issue":"68","key":"key20251209132257_b15-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2015.00068","article-title":"Early life stress effects on Glucocorticoid-BDNF interplay in the hippocampus","volume":"8","author":"Daskalakis","year":"2015","journal-title":"Front Mol Neurosci"},{"key":"key20251209132257_b16-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.pnpbp.2008.04.007","article-title":"Investigation of serum BDNF levels in drug-naive patients with schizophrenia","volume":"32","author":"Rizos","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key20251209132257_b17-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.schres.2011.03.011","article-title":"Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients","volume":"129","author":"Rizos","year":"2011","journal-title":"Schizophr Res"},{"key":"key20251209132257_b18-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000315438","article-title":"Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia","volume":"62","author":"Rizos","year":"2010","journal-title":"Neuropsychobiology"},{"key":"key20251209132257_b19-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.schres.2014.07.013","article-title":"Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis","volume":"159","author":"Theleritis","year":"2014","journal-title":"Schizophr Res"},{"key":"key20251209132257_b20-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/1873-3468.14985","article-title":"Age-associated myeloid malignancies-the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia","volume":"598","author":"Fasouli","year":"2024","journal-title":"FEBS Lett"},{"issue":"669363","key":"key20251209132257_b21-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.669363","article-title":"JAK-STAT in Early Hematopoiesis and Leukemia","volume":"9","author":"Fasouli","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"pt13","key":"key20251209132257_b22-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003622","article-title":"Protein complexes and target genes identification by in vivo biotinylation: The STAT5 paradigm","volume":"5","author":"Katsantoni","year":"2012","journal-title":"Sci Signal"},{"issue":"e76155","key":"key20251209132257_b23-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076155","article-title":"Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia","volume":"8","author":"Theodorou","year":"2013","journal-title":"PLoS One"},{"key":"key20251209132257_b24-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/nar\/gkw832","article-title":"The dual role of LSD1 and HDAC3 in STAT5-dependent transcription is determined by protein interactions, binding affinities, motifs and genomic positions","volume":"45","author":"Nanou","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"key20251209132257_b25-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/09727531211070532","article-title":"Role of JAK\/STAT in the Neuroinflammation and its association with neurological disorders","volume":"28","author":"Jain","year":"2021","journal-title":"Ann Neurosci"},{"key":"key20251209132257_b26-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbi.2018.11.317","article-title":"The JAK-STAT1 transcriptional signature in peripheral immune cells reveals alterations related to illness duration and acuity in psychosis","volume":"77","author":"Melbourne","year":"2019","journal-title":"Brain Behav Immun"},{"issue":"372","key":"key20251209132257_b27-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"Front Neurosci"},{"issue":"1356975","key":"key20251209132257_b28-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1356975","article-title":"Neuroinflammation and schizophrenia-is there a link?","volume":"15","author":"Chaves","year":"2024","journal-title":"Front Psychiatry"},{"key":"key20251209132257_b29-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.focus.20200015","article-title":"Evaluating the hypothesis that schizophrenia is an inflammatory disorder","volume":"18","author":"Miller","year":"2020","journal-title":"Focus"},{"issue":"140","key":"key20251209132257_b30-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020140","article-title":"Cytokines in the brain and neuroinflammation: We Didn't Starve the Fire!","volume":"15","author":"Konsman","year":"2022","journal-title":"Pharm Basel Switz"},{"issue":"536257","key":"key20251209132257_b31-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.536257","article-title":"Cytokine imbalance in schizophrenia. From research to clinic: Potential implications for treatment","volume":"12","author":"Reale","year":"2021","journal-title":"Front Psychiatry"},{"key":"key20251209132257_b32-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/revneuro-2018-0027","article-title":"Therapeutic potential of JAK\/STAT pathway modulation in mood disorders","volume":"30","author":"Shariq","year":"2018","journal-title":"Rev Neurosci"},{"issue":"160","key":"key20251209132257_b33-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00160","article-title":"The role of inflammation in the treatment of Schizophrenia","volume":"11","author":"Fond","year":"2020","journal-title":"Front Psychiatry"},{"issue":"677","key":"key20251209132257_b34-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-6033-2","article-title":"Evidence for a non-canonical JAK\/STAT signaling pathway in the synthesis of the brain's major ion channels and neurotransmitter receptors","volume":"20","author":"Hixson","year":"2019","journal-title":"BMC Genomics"},{"key":"key20251209132257_b35-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1038\/s41380-020-00904-2","article-title":"STAT3 in the dorsal raphe gates behavioural reactivity and regulates gene networks associated with psychopathology","volume":"26","author":"Reisinger","year":"2021","journal-title":"Mol Psychiatry"},{"key":"key20251209132257_b36-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ymthe.2024.11.011","article-title":"Novel insights into the ROCK-JAK-STAT signaling pathway in upper respiratory tract infections and neurodegenerative diseases","volume":"33","author":"Li","year":"2025","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"40","key":"key20251209132257_b37-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT signaling in inflammation and stress-related diseases: Implications for therapeutic interventions","volume":"4","author":"Sarapultsev","year":"2023","journal-title":"Mol Biomed"},{"issue":"167184","key":"key20251209132257_b38-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167184","article-title":"Schizophrenia risk candidate protein ZNF804A interacts with STAT2 and influences interferon-mediated gene transcription in mammalian cells","volume":"433","author":"Klockmeier","year":"2021","journal-title":"J Mol Biol"},{"key":"key20251209132257_b39-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000450581","article-title":"Activated phosphorylated STAT1 levels as a biologically relevant immune signal in Schizophrenia","volume":"23","author":"Sharma","year":"2016","journal-title":"Neuroimmunomodulation"},{"issue":"101606","key":"key20251209132257_b40-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101606","article-title":"Non-coding RNA-based regulation of inflammation","volume":"59","author":"Ashrafizadeh","year":"2022","journal-title":"Semin Immunol"},{"issue":"11","key":"key20251209132257_b41-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna4020011","article-title":"Non-coding RNA as novel players in the pathophysiology of schizophrenia","volume":"4","author":"Gibbons","year":"2018","journal-title":"Noncoding RNA"},{"issue":"44","key":"key20251209132257_b42-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0030-5","article-title":"Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease","volume":"8","author":"Liu","year":"2018","journal-title":"Transl Psychiatry"},{"issue":"640463","key":"key20251209132257_b43-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.640463","article-title":"A review on the expression pattern of Non-coding RNAs in patients with schizophrenia: With a special focus on peripheral blood as a source of expression analysis","volume":"12","author":"Ghafouri-Fard","year":"2021","journal-title":"Front Psychiatry"},{"issue":"995956","key":"key20251209132257_b44-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.995956","article-title":"The emerging role of long non-coding RNAs in schizophrenia","volume":"13","author":"Wu","year":"2022","journal-title":"Front Psychiatry"},{"issue":"11","key":"key20251209132257_b45-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00195-8","article-title":"LncRNA RP5-998N21.4 promotes immune defense through upregulation of IFIT2 and IFIT3 in schizophrenia","volume":"8","author":"Guo","year":"2022","journal-title":"Schizophrenia (Heidelb)"},{"key":"key20251209132257_b46-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1038\/s41380-020-0662-3","article-title":"LncRNA-AC006129.1 reactivates a SOCS3-mediated anti-inflammatory response through DNA methylation-mediated CIC downregulation in schizophrenia","volume":"26","author":"Ni","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"154657","key":"key20251209132257_b47-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154657","article-title":"The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer","volume":"248","author":"Hjazi","year":"2023","journal-title":"Pathol Res Pract"},{"issue":"445","key":"key20251209132257_b48-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02144-y","article-title":"Noncoding RNAs involved in the STAT3 pathway in glioma","volume":"21","author":"Bian","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"166","key":"key20251209132257_b49-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01674-z","article-title":"LINC00669 insulates the JAK\/STAT suppressor SOCS1 to promote nasopharyngeal cancer cell proliferation and invasion","volume":"39","author":"Qing","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"key20251209132257_b50-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.3892\/mmr.2016.5853","article-title":"miRNAs and their role in the correlation between schizophrenia and cancer","volume":"14","author":"Rizos","year":"2016","journal-title":"Mol Med Rep"},{"issue":"e0123522","key":"key20251209132257_b51-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135863","article-title":"Let-7, Mir-98 and Mir-181 as biomarkers for cancer and schizophrenia","volume":"10","author":"Rizos","year":"2015","journal-title":"PLoS One"},{"key":"key20251209132257_b52-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.3892\/or.2012.2052","article-title":"miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects","volume":"28","author":"Rizos","year":"2012","journal-title":"Oncol Rep"},{"issue":"149730","key":"key20251209132257_b53-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149730","article-title":"Mechanisms and clinical implications of microRNA associations and signaling pathways in B-cell acute lymphoblastic leukemia","volume":"967","author":"Dhiflaoui","year":"2025","journal-title":"Gene"},{"key":"key20251209132257_b54-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.15252\/embj.201489504","article-title":"Let-7 and miR-125 cooperate to prime progenitors for astrogliogenesis","volume":"34","author":"Shenoy","year":"2015","journal-title":"EMBO J"},{"key":"key20251209132257_b55-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.canlet.2014.01.020","article-title":"MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression","volume":"347","author":"Patel","year":"2014","journal-title":"Cancer Lett"},{"key":"key20251209132257_b56-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jhep.2009.12.043","article-title":"Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3","volume":"53","author":"Wang","year":"2010","journal-title":"J Hepatol"},{"key":"key20251209132257_b57-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1152\/physiolgenomics.00122.2013","article-title":"Interplay between microRNAs and the STAT3 signaling pathway in human cancers","volume":"45","author":"Cao","year":"2013","journal-title":"Physiol Genomics"},{"key":"key20251209132257_b58-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbi.2022.03.016","article-title":"Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-na\u00efve schizophrenia","volume":"103","author":"Lago","year":"2022","journal-title":"Brain Behav Immun"},{"key":"key20251209132257_b59-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"key20251209132257_b60-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/1535370215619707","article-title":"Possible involvement of the JAK\/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects","volume":"241","author":"Al-Samhari","year":"2016","journal-title":"Exp Biol Med"},{"issue":"514","key":"key20251209132257_b61-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-05014-1","article-title":"Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs\/JAK-STAT signaling pathway","volume":"23","author":"Long","year":"2023","journal-title":"BMC Psychiatry"},{"key":"key20251209132257_b62-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.critrevonc.2018.06.004","article-title":"Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma","volume":"128","author":"Elmaci","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20251209132257_b63-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcancer.2019.10.007","article-title":"Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy","volume":"68","author":"Shaw","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"402","key":"key20251209132257_b64-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: From bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"391","key":"key20251209132257_b65-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14040391","article-title":"Neuroinflammation and schizophrenia: New therapeutic strategies through psychobiotics, nanotechnology, and artificial intelligence (AI)","volume":"14","author":"Mosquera","year":"2024","journal-title":"J Personalized Med"},{"issue":"6","key":"key20251209132257_b66-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0054-x","article-title":"Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1","volume":"7","author":"Stachowiak","year":"2017","journal-title":"Transl Psychiatry"},{"issue":"189","key":"key20251209132257_b67-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00928-x","article-title":"Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients' postmortem brains","volume":"12","author":"Nascimento","year":"2022","journal-title":"Cell Biosci"},{"key":"key20251209132257_b68-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamapsychiatry.2020.0196","article-title":"Transcriptomic landscape and functional characterization of induced pluripotent stem Cell-derived cerebral organoids in schizophrenia","volume":"77","author":"Kathuria","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"3770","key":"key20251209132257_b69-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39420-6","article-title":"Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids","volume":"14","author":"Sebastian","year":"2023","journal-title":"Nat Commun"},{"key":"key20251209132257_b70-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"10630","DOI":"10.1021\/acsnano.4c10525","article-title":"Interfacing with the Brain: How nanotechnology can contribute","volume":"19","author":"Ahmed","year":"2025","journal-title":"ACS Nano"},{"key":"key20251209132257_b71-BR-24-1-02090","doi-asserted-by":"publisher","first-page":"490","DOI":"10.34172\/apb.2022.052","article-title":"Nanotechnology approaches for enhanced CNS drug delivery in the management of schizophrenia","volume":"12","author":"Rajendran","year":"2022","journal-title":"Adv Pharm Bull"},{"issue":"fasebj.2022.36.S1.R5716","key":"key20251209132257_b72-BR-24-1-02090","article-title":"Delivering MicroRNA-137 to the brain via nanoparticles","volume":"36","author":"Palumbo","year":"2022","journal-title":"FASEB J"},{"issue":"102222","key":"key20251209132257_b73-BR-24-1-02090","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102222","article-title":"The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment","volume":"28","author":"Radaic","year":"2020","journal-title":"Nanomedicine Nanotechnol Biol Med"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:23:25Z","timestamp":1765279405000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.2090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,21]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.2090","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"type":"print","value":"2049-9434"},{"type":"electronic","value":"2049-9442"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}